Phenylpropanolamine-containing products will remain on the market in Spain

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1271, 2001-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Search for Related Substances in Market Products Containing Enalapril Maleate as the Active Principle

By Pilatti C.   Ercolano I.   Torre M.   Chiale C.   Spinetto M.  

Drug Development and Industrial Pharmacy, Vol. 25, Iss. 6, 1999-05 ,pp. : 807-811

Informa Healthcare

Access to resources Recommend Favorite

Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion

By Liu J.   Zhang F.   McGinity J.W.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 52, Iss. 2, 2001-09 ,pp. : 181-190

Elsevier

Access to resources Recommend Favorite

Phenylpropanolamine withdrawal for decongestive uses challenged

By  

Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Dextropropoxyphene products withdrawn from US market

By  

Reactions Weekly, Vol. 1, Iss. 1329, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

EMA's public statement on the use of thujone-containing products

By  

Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite